Mesoblast Market Cap

Mesoblast has a market cap or net worth of 2.79 billion as of April 28, 2026. Its market cap has increased by 31.41% in one year.

Market Cap

2.79B

Enterprise Value

2.79B

Revenue

98.02M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.15

Market Cap Chart

Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 2.79B, an increase of 3,538.76%. That is a compound annual growth rate of 18.31%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	2.79B	-20.16%
Dec 31, 2025	3.49B	-1.80%
Dec 31, 2024	3.55B	1,029.56%
Dec 29, 2023	314.59M	-50.91%
Dec 30, 2022	640.82M	-29.87%
Dec 31, 2021	913.81M	-30.79%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Telix Pharmaceuticals	4.98B
Neuren Pharmaceuticals	1.54B
PYC Therapeutics	1.29B
Clarity Pharmaceuticals	1.16B
Opthea	738.77M
Racura Oncology	496.98M
Clinuvel Pharmaceuticals	452.84M
Starpharma Holdings	315.86M

Market Cap Rankings